Feasibility of VMAT and CBCT for Head and Neck Carcinomas
NCT ID: NCT01384890
Last Updated: 2013-02-06
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE1
20 participants
INTERVENTIONAL
2011-07-31
2012-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
1. VMAT for the treatment of patients with HNC will provide opportunities for image-guided radiotherapy using CBCT online correction to reduce systematic and random error.
2. Analysis of patient reported quality of life outcomes during VMAT, with and without CBCT acquisition, will be hypothesis generating.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Whole Brain Radiotherapy Versus Volumetric Modulated Arc Therapy for Brain Metastases
NCT02220491
Volumetric Modulated Arc Therapy (VMAT) for Brain Metastases
NCT01046123
Adaptive Radiation Therapy for Head & Neck Cancer Patients
NCT01853670
A Study of Conventional 3D Radiation vs. Intensity-Modulated Radiation in Squamous Cell Cancer of the Head and Neck
NCT00363441
Volumetric Intensity Modulated Arc Therapy vs. Conventional Radiotherapy for Cancer Pain
NCT03374592
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
VMAT with CBCT
Volumetric modulated arc therapy (VMAT) with cone-beam computed tomography position (CBCT) verification
VMAT with CBCT
volumetric modulated arc therapy (VMAT) with cone-beam computed tomography (CBCT) position verification
VMAT with kV-ray
Volumetric modulation arc therapy (VMAT) with kV-ray position verification
VMAT with kV-ray
Volumetric modulated arc therapy (VMAT) with kV-ray position verification
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
VMAT with CBCT
volumetric modulated arc therapy (VMAT) with cone-beam computed tomography (CBCT) position verification
VMAT with kV-ray
Volumetric modulated arc therapy (VMAT) with kV-ray position verification
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* undergoing radical radiation therapy for head and neck carcinoma at the BC Cancer Agency
Exclusion Criteria
* patient has received previous radiation for head and neck cancer
* patient has systemic lupus erythematosis or scleroderma
* patients has other autoimmune connective tissue disorders
18 Months
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
British Columbia Cancer Agency
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Jonn Wu
Dr. Jonn Wu
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jonn Wu, MD
Role: PRINCIPAL_INVESTIGATOR
British Columbia Cancer Agency
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
BC Cancer Agency - Vancouver Centre
Vancouver, British Columbia, Canada
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
VMAT, CBCT for H&N ca
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.